Feinglos MN - Search Results

1

Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice.

Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffé-Scrive M. Surwit RS, et al. Among authors: feinglos mn. Metabolism. 1995 May;44(5):645-51. doi: 10.1016/0026-0495(95)90123-x. Metabolism. 1995. PMID: 7752914

2

Therapy of insulin-independent diabetes mellitus: general considerations.

Lebovitz HE, Feinglos MN. Lebovitz HE, et al. Among authors: feinglos mn. Metabolism. 1980 May;29(5):474-81. doi: 10.1016/0026-0495(80)90173-0. Metabolism. 1980. PMID: 6990182

3

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.

Lebovitz HE, Feinglos MN, Bucholtz HK, Lebovitz FL. Lebovitz HE, et al. Among authors: feinglos mn. J Clin Endocrinol Metab. 1977 Sep;45(3):601-4. doi: 10.1210/jcem-45-3-601. J Clin Endocrinol Metab. 1977. PMID: 903405

4

Sulfonylurea treatment of insulin-independent diabetes mellitus.

Feinglos MN, Lebovitz HE. Feinglos MN, et al. Metabolism. 1980 May;29(5):488-94. doi: 10.1016/0026-0495(80)90175-4. Metabolism. 1980. PMID: 6990184

5

Combination insulin-sulfonylurea therapy in type II diabetes mellitus.

Allen BT, Feinglos MN. Allen BT, et al. Among authors: feinglos mn. South Med J. 1987 Oct;80(10):1285-9. doi: 10.1097/00007611-198710000-00019. South Med J. 1987. PMID: 3310252 Review. No abstract available.

6

Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus.

Rebuffé-Scrive M, Surwit R, Feinglos M, Kuhn C, Rodin J. Rebuffé-Scrive M, et al. Metabolism. 1993 Nov;42(11):1405-9. doi: 10.1016/0026-0495(93)90190-y. Metabolism. 1993. PMID: 8231834

7

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.

Feinglos MN, Saad MF, Pi-Sunyer FX, An B, Santiago O; Liraglutide Dose-Response Study Group. Feinglos MN, et al. Diabet Med. 2005 Aug;22(8):1016-23. doi: 10.1111/j.1464-5491.2005.01567.x. Diabet Med. 2005. PMID: 16026367 Clinical Trial.

8

Oral agents in the management of type 2 diabetes mellitus.

Luna B, Feinglos MN. Luna B, et al. Among authors: feinglos mn. Am Fam Physician. 2001 May 1;63(9):1747-56. Am Fam Physician. 2001. PMID: 11352285 Review.

9

Depressed mood is a factor in glycemic control in type 1 diabetes.

Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, Surwit RS. Van Tilburg MA, et al. Among authors: feinglos mn. Psychosom Med. 2001 Jul-Aug;63(4):551-5. doi: 10.1097/00006842-200107000-00005. Psychosom Med. 2001. PMID: 11485108

10

Diet-induced type II diabetes in C57BL/6J mice.

Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Surwit RS, et al. Among authors: feinglos mn. Diabetes. 1988 Sep;37(9):1163-7. doi: 10.2337/diab.37.9.1163. Diabetes. 1988. PMID: 3044882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results